secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2023-11-29T23:59:59+00:00
Accession:  0001558370-23-019380
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences raises $1.2M via warrant exercise with existing accredited investor
--------------------------------------------------------------------------------

- Gross proceeds ~$1.2M from exercise of 5,382,500 warrants at reduced price of $0.23/share.
- New warrants issued for 10,765,000 shares (200% coverage) at $0.23, exercisable in 6 months for 5.5 years.
- Exercise price of existing warrants reduced from $0.2503 to $0.23; also reduces price on 6,960,351 unexercised warrants.
- Beneficial ownership limits: 9.99% for existing, 4.99% for new warrants.
- Proceeds earmarked for commercial growth, working capital, and general corporate purposes. Maxim Group acted as agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000155837023019380/0001558370-23-019380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000155837023019380/rsls-20231121x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer